The purpose of this Management's Discussion and Analysis ("MD&A") is to provide an understanding of our financial condition and results of operations by focusing on changes in certain key measures from year-to-year. This MD&A is divided into the following sections:



•Executive summary

•Results of operations

•Segment results

•Liquidity and capital resources

•Regulatory matters

•Critical accounting policies and estimates



This MD&A should be read in conjunction with "Management's Discussion and
Analysis of Financial Condition and Results of Operations" included in Scotts
Miracle-Gro's Annual Report on Form 10-K for the fiscal year ended September 30,
2021 (the "2021 Annual Report") and our condensed consolidated financial
statements included in this Quarterly Report on Form 10-Q.

EXECUTIVE SUMMARY



Our operations are divided into three reportable segments: U.S. Consumer,
Hawthorne and Other. U.S. Consumer consists of our consumer lawn and garden
business in the United States. Hawthorne consists of our indoor and hydroponic
gardening business. Other primarily consists of our consumer lawn and garden
business outside the United States. This division of reportable segments is
consistent with how the segments report to and are managed by our chief
operating decision maker. In addition, Corporate consists of general and
administrative expenses and certain other income and expense items not allocated
to the reporting segments. See "SEGMENT RESULTS" below for additional
information regarding our evaluation of segment performance.

Through our U.S. Consumer and Other segments, we are the leading manufacturer
and marketer of branded consumer lawn and garden products in North America. Our
products are marketed under some of the most recognized brand names in the
industry. Our key consumer lawn and garden brands include Scotts® and Turf
Builder® lawn and grass seed products; Miracle-Gro® soil, plant food and
insecticide, LiquaFeed® plant food and Osmocote® gardening and landscape
products; and Ortho®, Home Defense® and Tomcat® branded insect control, weed
control and rodent control products. We are the exclusive agent of Monsanto for
the marketing and distribution of certain of Monsanto's consumer Roundup®
branded products within the United States and certain other specified countries.
We also have a presence in similar branded consumer products in China. In
addition, we own a 50% equity interest in Bonnie Plants, LLC, a joint venture
with AFC, focused on planting, growing, developing, distributing, marketing and
selling live plants.

Through our Hawthorne segment, we are the leading manufacturer, marketer and
distributor of lighting, nutrients, growing media, growing environments and
hardware products for indoor and hydroponic gardening in North America. Our key
brands include General Hydroponics®, Gavita®, Botanicare®, Agrolux®,
Can-Filters®, Gro Pro®, Mother Earth®, Hurricane®, Grower's Edge®, Hydro-Logic®
and Luxx Lighting®.

Due to the seasonal nature of the consumer lawn and garden business, for our
U.S. Consumer and Other segments, significant portions of our products ship to
our retail customers during our second and third fiscal quarters, as noted in
the following table. Our annual net sales are further concentrated in the second
and third fiscal quarters by retailers who rely on our ability to deliver
products closer to when consumers buy our products, thereby reducing retailers'
pre-season inventories. For our Hawthorne segment, sales are also impacted by
seasonal patterns for certain product categories due to the timing of outdoor
growing in North America during our second and third fiscal quarters, and the
timing of certain controlled agricultural lighting project sales during our
third and fourth fiscal quarters.
                             Percent of Net Sales from Continuing
                                     Operations by Quarter
                                 2021                       2020        2019
First Quarter                                  15.2  %      8.9  %      9.4  %
Second Quarter                                 37.1  %     33.5  %     37.7  %
Third Quarter                                  32.7  %     36.1  %     37.1  %
Fourth Quarter                                 15.0  %     21.5  %     15.8  %


                                       30

--------------------------------------------------------------------------------

  Contents             THE SCOTTS MIRACLE-GRO COMPANY
                (Dollars in millions, except per share data)


Recent Events

Our Hawthorne segment profit has been negatively impacted by an oversupply of
cannabis, which has slowed down indoor and outdoor cultivation, and higher
transportation and warehousing costs during the three and nine months ended
July 2, 2022. Due to the risks and uncertainties related to these impacts, we
performed interim impairment testing for Hawthorne long-lived assets and
goodwill during the third quarter of fiscal 2022, which resulted in non-cash,
pre-tax goodwill and intangible asset impairment charges of $632.4 recorded in
the "Impairment, restructuring and other" line in the Condensed Consolidated
Statements of Operations. The tax impact of the impairment charges was a benefit
of $138.0 for the three and nine months ended July 2, 2022 and was recorded in
the "Income tax expense (benefit) from continuing operations" line in the
Condensed Consolidated Statements of Operations. Refer to the "CRITICAL
ACCOUNTING POLICIES AND ESTIMATES" section of this MD&A and "NOTE 4. GOODWILL
AND INTANGIBLE ASSETS" for more information. We expect that the oversupply of
cannabis and cost increases will continue to adversely impact our Hawthorne
segment. In response, we are taking actions intended to mitigate the impact,
including reducing the size of our supply chain network, reducing staffing
levels and implementing other cost-reduction initiatives. If the oversupply of
cannabis and cost increases persist longer, or are more significant than we
expect or we are unable to mitigate their impact, our results of operations
could be adversely impacted for a longer period and to a greater extent than we
currently anticipate.

On April 8, 2022, we entered into the Sixth A&R Credit Agreement, providing us
with five-year senior secured loan facilities in the aggregate principal amount
of $2,500.0, comprised of a revolving credit facility of $1,500.0 and a term
loan in the original principal amount of $1,000.0. The Sixth A&R Credit
Agreement contains, among other obligations, an affirmative covenant regarding
our leverage ratio determined as of the end of each of our fiscal quarters. The
maximum permitted leverage ratio originally established in the Sixth A&R Credit
Agreement was 4.50. During the third quarter of fiscal 2022, we experienced an
unexpected shortfall in earnings that affected our ability to remain in
compliance with the leverage ratio covenant of the Sixth A&R Credit Agreement.
On June 8, 2022, we entered into Amendment No. 1 (the "Amendment") to the Sixth
A&R Credit Agreement which increased the maximum permitted leverage ratio for
the quarterly leverage covenant effective for the third quarter of fiscal 2022
until the earlier of (i) April 1, 2024 and (ii) subject to certain conditions
specified in the Amendment, the termination by us of such increase (such period,
the "Leverage Adjustment Period"). Refer to the "LIQUIDITY AND CAPITAL
RESOURCES" section of this MD&A for more information regarding the Amendment.

On December 30, 2021, our Hawthorne segment completed the acquisition of
substantially all of the assets of Luxx Lighting, Inc., a leading provider of
lighting products for indoor growing, for a purchase price of $213.2. On
April 28, 2022, our Hawthorne segment completed the acquisition of substantially
all of the assets of Cyco, an Australia-based provider of premium nutrients,
additives and growing media products for indoor growing, for a purchase price of
$37.4.

During fiscal 2021, we announced the creation of a newly formed subsidiary, THC,
to focus on strategic minority non-equity investments in areas of the cannabis
industry not currently pursued by our Hawthorne segment. This initiative is
designed to allow us, in the future, to participate directly in a larger
marketplace as the legal environment changes over time. On August 24, 2021, we
made our initial investment under this initiative in the form of a $150.0
six-year convertible note issued to us by RIV Capital, a cannabis investment and
acquisition firm listed on the Canadian Securities Exchange. On April 22, 2022,
pursuant to our follow-on investment rights, we made an additional investment in
RIV Capital in the form of a $25.0 convertible note. During the fourth quarter
of fiscal 2021, we made minority non-equity investments of $43.1 in other
entities focused on branded cannabis and high quality genetics. These
investments include conversion features that would provide us with minority
ownership interests in these entities if we exercise the conversion features.
Refer to "NOTE 3. ACQUISITIONS AND INVESTMENTS" for more information regarding
these investments.

On February 6, 2020, Scotts Miracle-Gro announced that its Board of Directors
authorized the repurchase of up to $750.0 of Common Shares from April 30, 2020
through March 25, 2023. During the three and nine months ended July 2, 2022,
Scotts Miracle-Gro repurchased 0.0 million and 1.1 million Common Shares under
this share repurchase authorization for $0.0 and $175.0, respectively. During
the three and nine months ended July 3, 2021, Scotts Miracle-Gro repurchased
0.1 million and 0.4 million Common Shares under this share repurchase
authorization for $25.0 and $75.6, respectively.

On July 27, 2020, the Scotts Miracle-Gro Board of Directors approved an increase
in Scott Miracle-Gro's quarterly cash dividend from $0.58 to $0.62 per Common
Share, which was first paid in the fourth quarter of fiscal 2020. On July 30,
2021, the Scotts Miracle-Gro Board of Directors approved an increase in Scott
Miracle-Gro's quarterly cash dividend from $0.62 to $0.66 per Common Share,
which was first paid in the fourth quarter of fiscal 2021.
                                       31
--------------------------------------------------------------------------------
  Contents             THE SCOTTS MIRACLE-GRO COMPANY
                (Dollars in millions, except per share data)


We have experienced higher transportation and materials costs, including
fertilizer inputs such as urea, due in part to the negative impact of the war in
Ukraine on the global economy. We expect a continuing inflationary environment
that is heightened by this conflict, and we are continuing to address these
impacts to our operations. We have no operations in Russia or Ukraine.

COVID-19



The COVID-19 pandemic has had, and continues to have, an impact on financial
markets, economic conditions, and portions of our business and industry. We have
actively addressed the pandemic's ongoing impact on our employees, operations,
customers, consumers, and communities, by, among other things, implementing
contingency plans, making operational adjustments where necessary, and providing
assistance to organizations that support front-line workers. The first priority
of our pandemic response has been and remains the health, safety and well-being
of our employees. In addition to implementing measures to help ensure the health
and safety of our employees, we implemented an interim premium pay allowance
during fiscal 2020 and 2021 for certain associates in our field sales force and
our manufacturing and distribution centers, which paid out nearly $50.0 in
aggregate during those two years.

The extent to which the COVID-19 pandemic will impact our business, results of
operations, financial condition and cash flows in the future will depend on
future developments, including the duration, spread and intensity of the
pandemic, our continued ability to manufacture and distribute our products, as
well as any future government actions affecting consumers and the economy
generally, all of which are uncertain and difficult to predict considering the
rapidly evolving landscape. We are not able to predict the impact, if any, that
the COVID-19 pandemic may have on the seasonality of our business.

Although we currently expect to be able to continue operating our business as
described above and we intend to continue to work with government authorities
and to follow the necessary protocols to maintain the health and safety of our
employees, the COVID-19 pandemic could result in additional disruptions to our
business, including our global supply chain and retailer network, and/or require
us to incur additional operational costs. For additional information on the
impacts of, and our response to, the COVID-19 pandemic, refer to "Management's
Discussion and Analysis of Financial Condition and Results of Operations" in
Part II, Item 7 of the 2021 Annual Report.

RESULTS OF OPERATIONS

The following table sets forth the components of earnings as a percentage of net sales for the three months ended July 2, 2022 and July 3, 2021:



                                                     July 2,                 % Of                July 3,                 % Of
                                                       2022               Net Sales                2021               Net Sales
Net sales                                          $ 1,186.1                    100.0  %       $ 1,609.7                    100.0  %
Cost of sales                                          883.7                     74.5            1,114.3                     69.2
Cost of sales-impairment, restructuring and other       65.8                      5.5                0.8                        -

Gross profit                                           236.6                     19.9              494.6                     30.7
Operating expenses:
Selling, general and administrative                    135.8                     11.4              194.1                     12.1
Impairment, restructuring and other                    658.4                     55.5                0.5                        -

Other (income) expense, net                              4.9                      0.4               (2.1)                    (0.1)
Income (loss) from operations                         (562.5)                   (47.4)             302.1                     18.8

Equity in income of unconsolidated affiliates          (15.1)                    (1.3)             (21.5)                    (1.3)

Interest expense                                        31.0                      2.6               21.9                      1.4
Other non-operating income, net                         (1.7)                    (0.1)              (1.2)                    (0.1)
Income (loss) from continuing operations before
income taxes                                          (576.7)                   (48.6)             302.9                     18.8
Income tax expense (benefit) from continuing
operations                                            (132.8)                   (11.2)              73.1                      4.5
Income (loss) from continuing operations              (443.9)                   (37.4)             229.8                     14.3
Loss from discontinued operations, net of tax              -                        -               (3.9)                    (0.2)
Net income (loss)                                  $  (443.9)                   (37.4) %       $   225.9                     14.0  %

The sum of the components may not equal due to rounding.


                                       32
--------------------------------------------------------------------------------
  Contents             THE SCOTTS MIRACLE-GRO COMPANY
                (Dollars in millions, except per share data)


The following table sets forth the components of earnings as a percentage of net sales for the nine months ended July 2, 2022 and July 3, 2021:



                                                     July 2,                 % Of                July 3,                 % Of
                                                       2022               Net Sales                2021               Net Sales
Net sales                                          $ 3,430.4                    100.0  %       $ 4,187.2                    100.0  %
Cost of sales                                        2,415.6                     70.4            2,822.2                     67.4
Cost of sales-impairment, restructuring and other       71.1                      2.1               22.2                      0.5

Gross profit                                           943.7                     27.5            1,342.8                     32.1
Operating expenses:
Selling, general and administrative                    494.6                     14.4              582.3                     13.9
Impairment, restructuring and other                    660.2                     19.2                3.7                      0.1

Other (income) expense, net                             (1.0)                       -               (3.4)                    (0.1)
Income (loss) from operations                         (210.1)                    (6.1)             760.2                     18.2

Equity in income of unconsolidated affiliates           (1.3)                       -              (20.0)                    (0.5)

Interest expense                                        83.1                      2.4               57.3                      1.4
Other non-operating income, net                         (5.4)                    (0.2)             (17.3)                    (0.4)
Income (loss) from continuing operations before
income taxes                                          (286.5)                    (8.4)             740.2                     17.7
Income tax expense (benefit) from continuing
operations                                             (69.0)                    (2.0)             174.2                      4.2
Income (loss) from continuing operations              (217.5)                    (6.3)             566.0                     13.5
Loss from discontinued operations, net of tax              -                        -               (4.7)                    (0.1)
Net income (loss)                                  $  (217.5)                    (6.3) %       $   561.3                     13.4  %

The sum of the components may not equal due to rounding.

Net Sales



Net sales for the three months ended July 2, 2022 were $1,186.1, a decrease of
26.3% from net sales of $1,609.7 for the three months ended July 3, 2021. Net
sales for the nine months ended July 2, 2022 were $3,430.4, a decrease of 18.1%
from net sales of $4,187.2 for the nine months ended July 3, 2021. These changes
in net sales were attributable to the following:

                            Three Months Ended      Nine Months Ended
                               July 2, 2022           July 2, 2022
Volume                                 (33.6) %               (25.1) %
Foreign exchange rates                  (0.4)                  (0.2)
Pricing                                  6.6                    6.3
Acquisitions                             1.1                    0.9

Change in net sales                    (26.3) %               (18.1) %


The decrease in net sales for the three and nine months ended July 2, 2022 as
compared to the three and nine months ended July 3, 2021 was primarily driven
by:

•decreased sales volume driven by lighting, nutrients, growing media, hardware and growing environments products in our Hawthorne segment; and lawn care, soils, controls, plant food and mulch products in our U.S. Consumer segment;

•decreased net sales associated with the Roundup® marketing agreement; and

•the unfavorable impact of foreign exchange rates as a result of the strengthening of the U.S. dollar relative to the euro and the Canadian dollar;

•partially offset by increased pricing in our U.S. Consumer, Hawthorne and Other segments; and

•the addition of net sales from acquisitions in our Hawthorne segment.


                                       33
--------------------------------------------------------------------------------

  Contents             THE SCOTTS MIRACLE-GRO COMPANY
                (Dollars in millions, except per share data)


Cost of Sales

The following table shows the major components of cost of sales for the periods
indicated:

                                                       Three Months Ended                     Nine Months Ended
                                                   July 2,            July 3,            July 2,            July 3,
                                                     2022               2021               2022               2021
Materials                                        $   495.2          $   622.1          $ 1,356.2          $ 1,617.1
Distribution and warehousing                         199.1              228.0              549.4              552.3
Manufacturing labor and overhead                     174.6              246.5              453.6              594.4
Costs associated with Roundup® marketing
agreement                                             14.8               17.7               56.4               58.4
Cost of sales                                        883.7            1,114.3            2,415.6            2,822.2
Cost of sales-impairment, restructuring and
other                                                 65.8                0.8               71.1               22.2

                                                 $   949.5          $ 1,115.1          $ 2,486.7          $ 2,844.4


Factors contributing to the change in cost of sales are outlined in the
following table:

                                                         Three Months Ended           Nine Months Ended
                                                            July 2, 2022                July 2, 2022
Volume, product mix and other                          $            (274.6)         $           (497.4)
Foreign exchange rates                                                (6.0)                       (6.3)
Costs associated with Roundup® marketing agreement                    (2.9)                       (2.0)
Material cost changes                                                 52.9                        99.1
                                                                    (230.6)                     (406.6)
Impairment, restructuring and other                                   65.0                        48.9

Change in cost of sales                                $            (165.6)         $           (357.7)


The decrease in cost of sales for the three and nine months ended July 2, 2022
as compared to the three and nine months ended July 3, 2021 was primarily driven
by:

•lower sales volume in our U.S. Consumer, Hawthorne and Other segments;

•the favorable impact of foreign exchange rates as a result of the strengthening of the U.S. dollar relative to the euro and the Canadian dollar; and

•a decrease in costs associated with the Roundup® marketing agreement;

•partially offset by higher material costs in our U.S. Consumer and Other segments;

•higher transportation and warehousing costs included within "volume, product mix and other" in our U.S. Consumer, Hawthorne and Other segments; and

•an increase in impairment, restructuring and other charges.


                                       34
--------------------------------------------------------------------------------

  Contents             THE SCOTTS MIRACLE-GRO COMPANY
                (Dollars in millions, except per share data)


Gross Profit

As a percentage of net sales, our gross profit rate was 19.9% and 30.7% for the
three months ended July 2, 2022 and July 3, 2021, respectively. As a percentage
of net sales, our gross profit rate was 27.5% and 32.1% for the nine months
ended July 2, 2022 and July 3, 2021, respectively. Factors contributing to the
change in gross profit rate are outlined in the following table:

                                           Three Months Ended      Nine Months Ended
                                              July 2, 2022           July 2, 2022
Volume, product mix and other                          (6.9) %                (5.4) %
Material costs                                         (4.9)                  (3.1)
Roundup® commissions and reimbursements                (0.9)                  (0.2)
Acquisitions                                           (0.2)                  (0.2)
Pricing                                                 7.6                    5.9

                                                       (5.3) %                (3.0) %
Impairment, restructuring and other                    (5.5)                

(1.6)



Change in gross profit rate                           (10.8) %              

(4.6) %




The decrease in gross profit rate for the three and nine months ended July 2,
2022 as compared to the three and nine months ended July 3, 2021 was primarily
driven by:

•higher material costs in our U.S. Consumer and Other segments;



•higher transportation and warehousing costs of 250 bps and 300 bps for the
three and nine months ended July 2, 2022, respectively, included within "volume,
product mix and other" associated with our U.S. Consumer, Hawthorne and Other
segments;

•unfavorable leverage of fixed costs driven by lower sales volume in our U.S. Consumer, Hawthorne and Other segments;

•decreased net sales associated with the Roundup® marketing agreement;

•an unfavorable net impact from acquisitions in our Hawthorne segment; and

•an increase in impairment, restructuring and other charges;

•partially offset by increased pricing in our U.S. Consumer, Hawthorne and Other segments.

Selling, General and Administrative Expenses

The following table sets forth the components of selling, general and administrative expenses ("SG&A") for the periods indicated:



                                                 Three Months Ended              Nine Months Ended
                                                July 2,          July 3,       July 2,        July 3,
                                                  2022            2021           2022          2021
Advertising                                 $     30.0          $  44.6      $     97.4      $ 140.1
Research and development                          10.4             11.4            35.3         32.0
Amortization of intangibles                        7.7              7.3            24.0         21.8
Share-based compensation                           5.5              8.1            28.6         34.0

Other selling, general and administrative         82.2            122.7           309.3        354.4
                                            $    135.8          $ 194.1      $    494.6      $ 582.3


SG&A decreased $58.3, or 30.0%, during the three months ended July 2, 2022
compared to the three months ended July 3, 2021. Advertising expense decreased
$14.6, or 32.7%, during the three months ended July 2, 2022 driven by decreased
media spending in our U.S. Consumer segment. Other SG&A decreased $40.5, or
33.0%, during the three months ended July 2, 2022 driven by a decrease in
short-term variable cash incentive compensation expense, reductions in staffing
levels and other cost-reduction initiatives.
                                       35
--------------------------------------------------------------------------------
  Contents             THE SCOTTS MIRACLE-GRO COMPANY
                (Dollars in millions, except per share data)


SG&A decreased $87.7, or 15.1%, during the nine months ended July 2, 2022
compared to the nine months ended July 3, 2021. Advertising expense decreased
$42.7, or 30.5%, during the nine months ended July 2, 2022 driven by decreased
media spending in our U.S. Consumer segment. Other SG&A decreased $45.1, or
12.7%, during the nine months ended July 2, 2022 driven by a decrease in
short-term variable cash incentive compensation expense, reductions in staffing
levels and other cost-reduction initiatives.

Impairment, Restructuring and Other



Activity described herein is classified within the "Cost of sales-impairment,
restructuring and other" and "Impairment, restructuring and other" lines in the
Condensed Consolidated Statements of Operations. The following table details
impairment, restructuring and other charges for each of the periods presented:

                                                            Three Months Ended                          Nine Months Ended
                                                        July 2,               July 3,              July 2,              July 3,
                                                         2022                   2021                 2022                 2021
Cost of sales-impairment, restructuring and
other:
COVID-19 related costs                            $         -               $     1.5          $        -             $    22.5
Restructuring and other charges (recoveries), net        58.8                    (0.7)               61.3                  (0.3)
Property, plant and equipment impairments                 7.0                       -                 9.8                     -
Operating expenses:
COVID-19 related costs                                      -                     0.4                   -                   3.6
Restructuring and other charges, net                     25.3                     0.1                27.1                   0.1
Goodwill and intangible asset impairments               633.1                       -               633.1                     -
Impairment, restructuring and other charges from
continuing operations                             $     724.2               $     1.3          $    731.3             $    25.9


During the three and nine months ended July 2, 2022, we recognized non-cash,
pre-tax goodwill and intangible asset impairment charges of $632.4 related to
our Hawthorne segment in the "Impairment, restructuring and other" line in the
Condensed Consolidated Statements of Operations, comprised of $522.4 of goodwill
impairment charges and $110.0 of finite-lived intangible asset impairment
charges.

During the three and nine months ended July 2, 2022, we incurred inventory
write-down charges of $45.9 in the "Cost of sales-impairment, restructuring and
other" line in the Condensed Consolidated Statements of Operations associated
with our decision to discontinue and exit the market for certain lighting
products and brands.

During the three and nine months ended July 2, 2022, we began implementing an
expanded series of organizational changes and initiatives intended to create
operational and management-level efficiencies. As part of this restructuring
program, we are reducing the size of our supply chain network, reducing staffing
levels and implementing other cost-reduction initiatives. During the three and
nine months ended July 2, 2022, we incurred costs of $40.7 and $46.1,
respectively, associated with this restructuring initiative primarily related to
employee termination benefits and impairment of property, plant and equipment.
We incurred costs of $9.5 in our U.S. Consumer segment and $10.4 and $15.6 in
our Hawthorne segment in the "Cost of sales-impairment, restructuring and other"
line in the Condensed Consolidated Statements of Operations during the three and
nine months ended July 2, 2022, respectively. We incurred costs of $7.4 in our
U.S. Consumer segment, $7.1 in our Hawthorne segment and $6.3 at Corporate in
the "Impairment, restructuring and other" line in the Condensed Consolidated
Statements of Operations during the three and nine months ended July 2, 2022,
respectively. We continue to evaluate additional network and organizational
changes, which, if executed, may result in additional restructuring charges in
future periods.

In response to the COVID-19 pandemic, we implemented measures intended to
protect the health and safety of our employees and maintain our ability to
provide products to our customers. Costs incurred during the three and nine
months ended July 2, 2022 related to COVID-19 were immaterial. During the three
and nine months ended July 3, 2021, we incurred costs of $1.9 and $26.1,
respectively, associated with the COVID-19 pandemic primarily related to premium
pay. We incurred costs of $0.8 and $19.8 in our U.S. Consumer segment, $0.5 and
$2.4 in our Hawthorne segment and $0.2 and $0.3 in our Other segment in the
"Cost of sales-impairment, restructuring and other" line in the Condensed
Consolidated Statements of Operations during the three and nine months ended
July 3, 2021, respectively. We incurred costs of $0.3 and $3.5 in our U.S.
Consumer segment and $0.1 in our Other segment in the "Impairment, restructuring
and other" line in the Condensed Consolidated Statements of Operations during
the three and nine months ended July 3, 2021, respectively.
                                       36
--------------------------------------------------------------------------------
  Contents             THE SCOTTS MIRACLE-GRO COMPANY
                (Dollars in millions, except per share data)


Other (Income) Expense, net



Other (income) expense is comprised of activities such as royalty income from
the licensing of certain of our brand names, foreign exchange transaction gains
and losses and gains and losses from the disposition of non-inventory assets.
Other (income) expense was $4.9 and $(2.1) for the three months ended July 2,
2022 and July 3, 2021, respectively; and was $(1.0) and $(3.4) for the nine
months ended July 2, 2022 and July 3, 2021, respectively. The change for the
three and nine months ended July 2, 2022 was primarily due to foreign exchange
transaction gains and losses.

Income (Loss) from Operations



Income (loss) from operations was $(562.5) for the three months ended July 2,
2022, a decrease of 286.2% compared to $302.1 for the three months ended July 3,
2021; and was $(210.1) for the nine months ended July 2, 2022, a decrease of
127.6% compared to $760.2 for the nine months ended July 3, 2021. For the three
and nine months ended July 2, 2022, the decrease was driven by lower net sales,
a decrease in gross profit rate, higher impairment, restructuring and other
charges and lower other income, partially offset by lower SG&A.

Equity in Income of Unconsolidated Affiliates



We acquired a 50% equity interest in Bonnie Plants, LLC on December 31, 2020.
Our interest is accounted for using the equity method of accounting, with our
proportionate share of Bonnie Plants, LLC earnings subsequent to December 31,
2020 reflected in the Condensed Consolidated Statements of Operations. We
recorded equity in income of unconsolidated affiliates associated with Bonnie
Plants, LLC of $15.1 and $1.3 during the three and nine months ended July 2,
2022, respectively, as compared to $21.5 and $20.0 during the three and nine
months ended July 3, 2021, respectively.

Interest Expense



Interest expense was $31.0 for the three months ended July 2, 2022, an increase
of 41.6% compared to $21.9 for the three months ended July 3, 2021. The increase
was driven by higher average borrowings of $1,307.4 due to higher inventory
production, capital expenditures, acquisition activity and repurchases of our
Common Shares.

Interest expense was $83.1 for the nine months ended July 2, 2022, an increase
of 45.0% compared to $57.3 for the nine months ended July 3, 2021. The increase
was driven by higher average borrowings of $1,131.4 due to higher inventory
production, capital expenditures, acquisition activity and repurchases of our
Common Shares.

Other Non-Operating Income, Net



Other non-operating income was $1.7 and $1.2 for the three months ended July 2,
2022 and July 3, 2021, respectively, and was $5.4 and $17.3 for the nine months
ended July 2, 2022 and July 3, 2021, respectively. On December 31, 2020, we
acquired a 50% equity interest in Bonnie Plants, LLC in exchange for cash
payments of $102.3, forgiveness of our outstanding loan receivable with AFC and
surrender of our options to increase our economic interest in the Bonnie Plants
business. Our loan receivable with AFC, which was previously recognized in the
"Other assets" line in the Condensed Consolidated Balance Sheets, had a carrying
value of $66.4 on December 31, 2020 and we recognized a gain of $12.5 during the
three months ended January 2, 2021 to write-up the value of the loan to its
closing date fair value of $78.9.

Income Tax Expense (Benefit) from Continuing Operations



The effective tax rates related to continuing operations for the nine months
ended July 2, 2022 and July 3, 2021 were 24.1% and 23.5%, respectively. The
effective tax rate used for interim purposes is based on our best estimate of
factors impacting the effective tax rate for the full fiscal year. Factors
affecting the estimated effective tax rate include assumptions as to income by
jurisdiction (domestic and foreign), the availability and utilization of tax
credits and the existence of elements of income and expense that may not be
taxable or deductible. The estimated effective tax rate is subject to revision
in later interim periods and at fiscal year-end as facts and circumstances
change during the course of the fiscal year. There can be no assurance that the
effective tax rate estimated for interim financial reporting purposes will
approximate the effective tax rate determined at fiscal year-end.

During the three and nine months ended July 2, 2022, we recognized non-cash,
pre-tax goodwill and intangible asset impairment charges of $632.4 related to
our Hawthorne segment in the "Impairment, restructuring and other" line in the
Condensed Consolidated Statements of Operations. The tax impact of the
impairment charges was a benefit of $138.0, which is net of the impact of
non-deductible goodwill of $18.5, for the three and nine months ended July 2,
2022 and was recorded in the "Income tax expense (benefit) from continuing
operations" line in the Condensed Consolidated Statements of Operations. The tax
impact of non-deductible goodwill was considered a discrete item because we have
no remaining non-deductible goodwill.
                                       37
--------------------------------------------------------------------------------
  Contents             THE SCOTTS MIRACLE-GRO COMPANY
                (Dollars in millions, except per share data)


This discrete item decreased the effective tax rate by approximately 640 bps for
the nine months ended July 2, 2022 because we incurred a net loss during this
period.

Income (Loss) from Continuing Operations



Income (loss) from continuing operations was $(443.9), or $(8.01) per diluted
share, for the three months ended July 2, 2022 compared to $229.8, or $4.00 per
diluted share, for the three months ended July 3, 2021. The decrease was driven
by lower net sales, a decrease in gross profit rate, higher impairment,
restructuring and other charges, lower other income, lower equity in income of
unconsolidated affiliates and higher interest expense, partially offset by lower
SG&A.

Diluted average common shares used in the diluted loss per common share
calculation for the three months ended July 2, 2022 were 55.4 million, which
excluded potential Common Shares of 0.4 million because the effect of their
inclusion would be anti-dilutive as we incurred a net loss for the three months
ended July 2, 2022. Diluted average common shares used in the diluted income per
common share calculation for the three months ended July 3, 2021 were 57.4
million, which included dilutive potential Common Shares of 1.6 million.

Income (loss) from continuing operations was $(217.5), or $(3.91) per diluted
share, for the nine months ended July 2, 2022 compared to $566.0, or $9.90 per
diluted share, for the nine months ended July 3, 2021. The decrease was driven
by lower net sales, a decrease in gross profit rate, higher impairment,
restructuring and other charges, lower other income, lower equity in income of
unconsolidated affiliates, higher interest expense and lower other non-operating
income, partially offset by lower SG&A.

Diluted average common shares used in the diluted loss per common share
calculation for the nine months ended July 2, 2022 were 55.6 million, which
excluded potential Common Shares of 0.6 million because the effect of their
inclusion would be anti-dilutive as we incurred a net loss for the nine months
ended July 2, 2022. Diluted average common shares used in the diluted income per
common share calculation for the nine months ended July 3, 2021 were
57.1 million, which included dilutive potential Common Shares of 1.4 million.

SEGMENT RESULTS

The following table sets forth net sales by segment:



                    Three Months Ended            Nine Months Ended
                  July 2,        July 3,        July 2,        July 3,
                   2022           2021           2022           2021
U.S. Consumer   $   904.5      $ 1,046.2      $ 2,626.7      $ 2,828.4
Hawthorne           154.5          421.9          547.7        1,095.1
Other               127.1          141.6          256.0          263.7
Consolidated    $ 1,186.1      $ 1,609.7      $ 3,430.4      $ 4,187.2


                                       38

--------------------------------------------------------------------------------
  Contents             THE SCOTTS MIRACLE-GRO COMPANY
                (Dollars in millions, except per share data)


The performance of each reportable segment is evaluated based on several
factors, including income (loss) from continuing operations before income taxes,
amortization, impairment, restructuring and other charges ("Segment Profit
(Loss)"), which is a non-GAAP financial measure. Senior management uses Segment
Profit (Loss) to evaluate segment performance because they believe this measure
is indicative of performance trends and the overall earnings potential of each
segment. The following table sets forth Segment Profit (Loss) as well as a
reconciliation to income from continuing operations before income taxes, the
most directly comparable GAAP measure:

                                                            Three Months Ended                     Nine Months Ended
                                                        July 2,             July 3,            July 2,            July 3,
                                                          2022               2021               2022               2021
U.S. Consumer                                        $     181.1          $  264.4          $    620.7          $  745.6
Hawthorne                                                    4.1              51.9                 2.0             133.7
Other                                                       10.9              26.8                22.7              44.4
Total Segment Profit (Non-GAAP)                            196.1             343.1               645.4             923.7
Corporate                                                  (25.2)            (31.9)              (95.7)           (114.6)
Intangible asset amortization                               (9.2)             (7.8)              (28.5)            (23.0)

Impairment, restructuring and other                       (724.2)             (1.3)             (731.3)            (25.9)
Equity in income of unconsolidated affiliates               15.1              21.5                 1.3              20.0

Interest expense                                           (31.0)            (21.9)              (83.1)            (57.3)
Other non-operating income, net                              1.7               1.2                 5.4              17.3
Income (loss) from continuing operations before
income taxes (GAAP)                                  $    (576.7)         $  302.9          $   (286.5)         $  740.2


U.S. Consumer

U.S. Consumer segment net sales were $904.5 in the third quarter of fiscal 2022,
a decrease of 13.5% from third quarter of fiscal 2021 net sales of $1,046.2; and
were $2,626.7 for the first nine months of fiscal 2022, a decrease of 7.1% from
the first nine months of fiscal 2021 net sales of $2,828.4. For the third
quarter of fiscal 2022, the decrease was driven by lower sales volume of 20.0%,
partially offset by increased pricing of 6.5%. For the nine months ended July 2,
2022, the decrease was driven by lower sales volume of 14.1%, partially offset
by increased pricing of 7.0%. The decrease in sales volume for the three and
nine months ended July 2, 2022 was driven by lawn care, soils, controls, plant
food and mulch products.

U.S. Consumer Segment Profit was $181.1 in the third quarter of fiscal 2022, a
decrease of 31.5% from the third quarter of fiscal 2021 Segment Profit of
$264.4; and Segment Profit was $620.7 for the first nine months of fiscal 2022,
a decrease of 16.8% from the first nine months of fiscal 2021 Segment Profit of
$745.6. For the three and nine months ended July 2, 2022, the decrease was
primarily due to lower net sales and a lower gross profit rate, partially offset
by lower SG&A.

Hawthorne

Hawthorne segment net sales were $154.5 in the third quarter of fiscal 2022, a
decrease of 63.4% from third quarter of fiscal 2021 net sales of $421.9; and
were $547.7 for the first nine months of fiscal 2022, a decrease of 50.0% from
the first nine months of fiscal 2021 net sales of $1,095.1. For the third
quarter of fiscal 2022, the decrease was driven by lower sales volume and
unfavorable foreign exchange rates of 73.2% and 0.3%, respectively, partially
offset by increased pricing and acquisitions of 5.7% and 4.4%, respectively. For
the nine months ended July 2, 2022, the decrease was driven by lower sales
volume and unfavorable foreign exchange rates of 57.2% and 0.2%, respectively,
partially offset by increased pricing and acquisitions of 4.1% and 3.3%,
respectively. The decrease in sales volume for the three and nine months ended
July 2, 2022 was driven by lighting, nutrients, growing media, hardware and
growing environments products.

Hawthorne Segment Profit was $4.1 in the third quarter of fiscal 2022, a
decrease of 92.1% from the third quarter of fiscal 2021 Segment Profit of $51.9;
and Segment Profit was $2.0 for the first nine months of fiscal 2022, a decrease
of 98.5% from the first nine months of fiscal 2021 Segment Profit of $133.7. For
the three and nine months ended July 2, 2022, the decrease was driven by lower
net sales and a lower gross profit rate, partially offset by lower SG&A.

Other



Other segment net sales were $127.1 in the third quarter of fiscal 2022, a
decrease of 10.2% from the third quarter of fiscal 2021 net sales of $141.6; and
were $256.0 for the first nine months of fiscal 2022, a decrease of 2.9% from
the first nine months of fiscal 2021 net sales of $263.7. For the third quarter
of fiscal 2022, the decrease was driven by lower sales volume
                                       39
--------------------------------------------------------------------------------
  Contents             THE SCOTTS MIRACLE-GRO COMPANY
                (Dollars in millions, except per share data)


and unfavorable foreign exchange rates of 16.1% and 4.0%, respectively,
partially offset by increased pricing of 9.9%. For the nine months ended July 2,
2022, the decrease was driven by lower sales volume and unfavorable foreign
exchange rates of 8.9% and 1.8%, respectively, partially offset by increased
pricing of 7.8%.

Other Segment Profit was $10.9 in the third quarter of fiscal 2022, a decrease
of 59.3% from the third quarter of fiscal 2021 Segment Profit of $26.8; and
Segment Profit was $22.7 for the first nine months of fiscal 2022, a decrease of
48.9% from the first nine months of fiscal 2021 Segment Profit of $44.4. For the
three and nine months ended July 2, 2022, the decrease was driven by lower net
sales and a lower gross profit rate, partially offset by lower SG&A.

Corporate



Corporate expenses were $25.2 in the third quarter of fiscal 2022, a decrease of
21.0% from the third quarter of fiscal 2021 expenses of $31.9; and were $95.7
for the first nine months of fiscal 2022, a decrease of 16.5% from the first
nine months of fiscal 2021 expenses of $114.6. For the three and nine months
ended July 2, 2022, the decrease was driven by lower short-term variable cash
incentive compensation expense, reductions in staffing levels and other
cost-reduction initiatives.

LIQUIDITY AND CAPITAL RESOURCES

The following table summarizes cash activities:



                                                Nine Months Ended
                                              July 2,       July 3,
                                               2022           2021

Net cash used in operating activities $ (679.6) $ (207.1) Net cash used in investing activities (334.5) (211.9) Net cash provided by financing activities 797.9 459.6

Operating Activities



Cash used in operating activities totaled $679.6 for the nine months ended
July 2, 2022, an increase of $472.5 as compared to $207.1 for the nine months
ended July 3, 2021. This increase was driven by higher inventory, lower net
income and higher interest payments, partially offset by lower tax payments and
lower short-term variable cash incentive compensation payouts. Higher inventory
was driven by higher production and higher input costs. The nine months ended
July 2, 2022 was also impacted by extended payment terms with several of our
major vendors across the U.S. Consumer and Hawthorne segments, as well as
Monsanto, for payments originally due in the final weeks of fiscal 2021 that
were paid in the first quarter of fiscal 2022.

Investing Activities



Cash used in investing activities totaled $334.5 for the nine months ended
July 2, 2022, an increase of $122.6 as compared to $211.9 for the nine months
ended July 3, 2021. Cash used for investments in property, plant and equipment
during the first nine months of fiscal 2022 and 2021 was $99.0 and $77.9,
respectively. We also completed the acquisitions of Luxx Lighting, Inc., True
Liberty Bags and Cyco during the nine months ended July 2, 2022 in exchange for
cash payments of $237.3, as well as the issuance of 0.1 million Common Shares, a
non-cash investing and financing activity, with a fair value of $21.0 based on
the share price at the time of payment. In addition, during the nine months
ended July 2, 2022, we made payments of $25.0 in connection with a minority
non-equity convertible debt investment, received proceeds from the sale of
long-lived assets of $9.4 and received $17.4 associated with currency forward
contracts. During the nine months ended July 3, 2021, we acquired a 50% equity
interest in Bonnie Plants, LLC in exchange for cash payments of $102.3, as well
as non-cash investing activities that included forgiveness of our outstanding
loan receivable with AFC and surrender of our options to increase our economic
interest in the Bonnie Plants business. In addition, during the nine months
ended July 3, 2021, we acquired contract and license rights within our U.S.
Consumer segment for $20.0 and we paid cash of $10.0 associated with currency
forward contracts.

Financing Activities

Cash provided by financing activities totaled $797.9 for the nine months ended
July 2, 2022 as compared $459.6 for the nine months ended July 3, 2021. This
change was driven by an increase in net borrowings under our Fifth A&R Credit
Facilities of $1,019.7 during the nine months ended July 2, 2022, partially
offset by the issuance of $500.0 aggregate principal amount of 4.00% Senior
Notes during the nine months ended July 3, 2021, an increase in repurchases of
our Common Shares of $166.7, an increase in dividends paid of $23.5 and a
decrease in cash received from exercise of stock options of $11.7. In addition,
we paid financing and issuance fees of $9.7 and $7.2 for the nine months ended
July 2, 2022 and July 3, 2021,
                                       40
--------------------------------------------------------------------------------
  Contents             THE SCOTTS MIRACLE-GRO COMPANY
                (Dollars in millions, except per share data)


respectively. We also made payments of $17.4 associated with the acquisition of the remaining outstanding shares of AeroGrow during the nine months ended July 3, 2021.

Cash and Cash Equivalents



Our cash and cash equivalents were held in cash depository accounts with major
financial institutions around the world or invested in high-quality, short-term
liquid investments having original maturities of three months or less. The cash
and cash equivalents balances of $27.8, $58.3 and $244.1 as of July 2, 2022,
July 3, 2021 and September 30, 2021, respectively, included $4.0, $52.1 and
$15.9, respectively, held by controlled foreign corporations. As of July 2,
2022, we maintain our assertion of indefinite reinvestment of the earnings of
all material foreign subsidiaries.

Borrowing Agreements

Credit Facilities



Our primary sources of liquidity are cash generated by operations and borrowings
under our credit facilities, which are guaranteed by substantially all of Scotts
Miracle-Gro's domestic subsidiaries. On July 5, 2018, we entered into a fifth
amended and restated credit agreement (the "Fifth A&R Credit Agreement"), which
provided us with five-year senior secured loan facilities in the aggregate
principal amount of $2,300.0, comprised of a revolving credit facility of
$1,500.0 and a term loan in the original principal amount of $800.0 (the "Fifth
A&R Credit Facilities"). Under the Fifth A&R Credit Facilities, we had the
ability to obtain letters of credit up to $75.0.

On April 8, 2022, we entered into a sixth amended and restated credit agreement
(the "Sixth A&R Credit Agreement"), providing us with five-year senior secured
loan facilities in the aggregate principal amount of $2,500.0, comprised of a
revolving credit facility of $1,500.0 and a term loan in the original principal
amount of $1,000.0 (the "Sixth A&R Credit Facilities"). The Sixth A&R Credit
Agreement also provides us with the right to seek additional committed credit
under the agreement in an aggregate amount of up to $500.0 plus an unlimited
additional amount, subject to certain specified financial and other conditions.
The Sixth A&R Credit Agreement replaces the Fifth A&R Credit Agreement and will
terminate on April 8, 2027. The Sixth A&R Credit Facilities are available for
issuance of letters of credit up to $100.0. The terms of the Sixth A&R Credit
Agreement include customary representations and warranties, affirmative and
negative covenants, financial covenants, and events of default.

At July 2, 2022, we had letters of credit outstanding in the aggregate principal
amount of $14.1 and had $868.5 of borrowing availability under the Sixth A&R
Credit Agreement. The weighted average interest rates on average borrowings
under the Fifth A&R Credit Agreement and Sixth A&R Credit Agreement were 2.1%
and 1.8% for the nine months ended July 2, 2022 and July 3, 2021, respectively.

Under the terms of the Sixth A&R Credit Agreement, loans bear interest, at our
election, at a rate per annum equal to either (i) the Alternate Base Rate plus
the Applicable Spread (each, as defined in the Sixth A&R Credit Agreement) or
(ii) the Adjusted Term SOFR Rate for the Interest Period in effect for such
borrowing plus the Applicable Spread (all as defined in the Sixth A&R Credit
Agreement). Swingline Loans bear interest at the applicable Swingline Rate set
forth in the Sixth A&R Credit Agreement. Further, interest rates for other
select non-U.S. dollar borrowings, including borrowings denominated in euro,
Pounds Sterling and Canadian Dollars, are based on separate interest rate
indices, as set forth in the Sixth A&R Credit Agreement. The Sixth A&R Credit
Agreement is secured by (i) a perfected first priority security interest in all
of the accounts receivable, inventory and equipment of Scotts Miracle-Gro and
certain of its domestic subsidiaries and (ii) the pledge of all of the capital
stock of certain of Scotts Miracle-Gro's domestic subsidiaries and a portion of
the capital stock of certain of its foreign subsidiaries. The collateral does
not include any of our intellectual property.

On June 8, 2022, we entered into Amendment No. 1 (the "Amendment") to the Sixth
A&R Credit Agreement. The Amendment increased the maximum permitted leverage
ratio for the quarterly leverage covenant effective for the third quarter of
fiscal 2022 until the earlier of (i) April 1, 2024 and (ii) subject to certain
conditions specified in the Amendment, the termination by us of such increase
(such period, the "Leverage Adjustment Period"). The Amendment also increases
the interest rate applicable to borrowings under the revolving credit facility
by 35 bps and the term loan facility by 50 bps, and increases the annual
facility fee rate on the revolving credit facility by 15 bps, in each case, when
our quarterly-tested leverage ratio exceeds 4.75. Additionally, the Amendment
limits our ability to declare or pay any discretionary dividends, distributions
or other restricted payments during the Leverage Adjustment Period to only the
payment of (i) regularly scheduled cash dividends to holders of our Common
Shares in an aggregate amount not to exceed $225.0 per fiscal year and (ii)
other dividends, distributions or other restricted payments in an aggregate
amount not to exceed $25.0; and requires pro forma compliance with certain
leverage levels specified in the Amendment with respect to our ability to
consummate certain acquisitions and incur debt.
                                       41
--------------------------------------------------------------------------------
  Contents             THE SCOTTS MIRACLE-GRO COMPANY
                (Dollars in millions, except per share data)


The Sixth A&R Credit Agreement contains, among other obligations, an affirmative
covenant regarding our leverage ratio determined as of the end of each of our
fiscal quarters calculated as average total indebtedness, divided by our
earnings before interest, taxes, depreciation and amortization, as adjusted
pursuant to the terms of the Sixth A&R Credit Agreement ("Adjusted EBITDA").
Pursuant to the Amendment, the maximum permitted leverage ratio is (i) 6.25 for
the third quarter of fiscal 2022 through the first quarter of fiscal 2023, (ii)
6.50 for the second and third quarters of fiscal 2023, (iii) 6.25 for the fourth
quarter of fiscal 2023 and the first quarter of fiscal 2024, (iv) 5.50 for the
second quarter of fiscal 2024, and (v) 4.50 for the third quarter of fiscal 2024
and thereafter. Our leverage ratio was 5.10 at July 2, 2022. The Sixth A&R
Credit Agreement also contains an affirmative covenant regarding our interest
coverage ratio determined as of the end of each of our fiscal quarters. The
interest coverage ratio is calculated as Adjusted EBITDA divided by interest
expense, as described in the Sixth A&R Credit Agreement, and excludes costs
related to refinancings. The minimum required interest coverage ratio is 3.00,
which is unchanged from the Fifth A&R Credit Agreement. Our interest coverage
ratio was 5.89 for the twelve months ended July 2, 2022. As of July 2, 2022, we
were in compliance with these financial covenants.

We continue to monitor our compliance with the leverage ratio, interest coverage
ratio and other covenants contained in the Sixth A&R Credit Agreement and, based
upon our current operating assumptions, we expect to remain in compliance with
the permissible leverage ratio and interest coverage ratio throughout fiscal
2022. However, an unanticipated shortfall in earnings, an increase in net
indebtedness or other factors could materially affect our ability to remain in
compliance with the financial or other covenants of the Sixth A&R Credit
Agreement, potentially causing us to have to seek an amendment or waiver from
our lending group which could result in, among other things, repricing of the
Sixth A&R Credit Agreement and/or immediate repayment of outstanding borrowings.
While we believe we have good relationships with our lending group, we can
provide no assurance that such a request would result in a modified or
replacement credit agreement on reasonable terms, if at all.

Senior Notes



On December 15, 2016, Scotts Miracle-Gro issued $250.0 aggregate principal
amount of 5.250% Senior Notes due 2026. The 5.250% Senior Notes represent
general unsecured senior obligations and rank equal in right of payment with our
existing and future unsecured senior debt. The 5.250% Senior Notes have interest
payment dates of June 15 and December 15 of each year.

On October 22, 2019, Scotts Miracle-Gro issued $450.0 aggregate principal amount
of 4.500% Senior Notes due 2029. The 4.500% Senior Notes represent general
unsecured senior obligations and rank equal in right of payment with our
existing and future unsecured senior debt. The 4.500% Senior Notes have interest
payment dates of April 15 and October 15 of each year.

On March 17, 2021, Scotts Miracle-Gro issued $500.0 aggregate principal amount
of 4.000% Senior Notes due 2031. The 4.000% Senior Notes represent general
unsecured senior obligations and rank equal in right of payment with our
existing and future unsecured senior debt. The 4.000% Senior Notes have interest
payment dates of April 1 and October 1 of each year.

On August 13, 2021, Scotts Miracle-Gro issued $400.0 aggregate principal amount
of 4.375% Senior Notes due 2032. The 4.375% Senior Notes represent general
unsecured senior obligations and rank equal in right of payment with our
existing and future unsecured senior debt. The 4.375% Senior Notes have interest
payment dates of February 1 and August 1 of each year.

Substantially all of Scotts Miracle-Gro's directly and indirectly owned domestic
subsidiaries serve as guarantors of the 5.250% Senior Notes, the 4.500% Senior
Notes, the 4.000% Senior Notes and the 4.375% Senior Notes.

Receivables Facility



We also maintain a Receivables Facility, under which we may sell a portfolio of
available and eligible outstanding customer accounts receivable to the
purchasers and simultaneously agree to repurchase the receivables on a weekly
basis. The eligible accounts receivable consist of accounts receivable generated
by sales to three specified customers. The eligible amount of customer accounts
receivables which may be sold under the Receivables Facility is $400.0 and the
commitment amount during the seasonal commitment period that began on
February 25, 2022 and ended on June 17, 2022 was $160.0. The Receivables
Facility expires on August 19, 2022 but is expected to be renewed prior to its
expiration.

We account for the sale of receivables under the Receivables Facility as short-term debt and continue to carry the receivables on our Condensed Consolidated Balance Sheets, primarily as a result of our requirement to repurchase receivables sold. As of July 2, 2022 and July 3, 2021, there were $250.0 and $0.0, respectively, in borrowings on receivables pledged as collateral under the Receivables Facility, and the carrying value of the receivables pledged as collateral was $277.8 and $0.0, respectively.


                                       42
--------------------------------------------------------------------------------
  Contents             THE SCOTTS MIRACLE-GRO COMPANY
                (Dollars in millions, except per share data)


Interest Rate Swap Agreements



We enter into interest rate swap agreements with major financial institutions
that effectively convert a portion of our variable rate debt to a fixed rate.
Interest payments made between the effective date and expiration date are hedged
by the swap agreements. Swap agreements that were hedging interest payments as
of July 2, 2022, July 3, 2021 and September 30, 2021 had a maximum total
U.S. dollar equivalent notional amount of $800.0, $700.0 and $600.0,
respectively. The notional amount, effective date, expiration date and rate of
each of the swap agreements outstanding at July 2, 2022 are shown in the table
below:

 Notional          Effective        Expiration       Fixed
  Amount            Date (a)           Date           Rate

   100              12/21/2020         6/20/2023     1.36  %
   300      (b)       1/7/2021          6/7/2023     1.34  %
   200               10/7/2021          6/7/2023     1.37  %
   200      (b)      1/20/2022         6/20/2024     0.58  %
   200                6/7/2023          6/8/2026     0.85  %


(a)The effective date refers to the date on which interest payments are first
hedged by the applicable swap agreement.
(b)Notional amount adjusts in accordance with a specified seasonal schedule.
This represents the maximum notional amount at any point in time.

Availability and Use of Cash



We believe that our cash flows from operations and borrowings under our
agreements described herein will be sufficient to meet debt service, capital
expenditures and working capital needs for the foreseeable future. However, we
cannot ensure that our business will generate sufficient cash flow from
operations or that future borrowings will be available under our borrowing
agreements in amounts sufficient to pay indebtedness or fund other liquidity
needs. Additionally, the extent to which the COVID-19 pandemic will ultimately
impact our business, results of operations, financial condition and cash flows
depends on future developments that are uncertain and difficult to predict.
Actual results of operations will depend on numerous factors, many of which are
beyond our control as further discussed in the 2021 Annual Report, under "ITEM
1A. RISK FACTORS - Risks Related to Our M&A, Lending and Financing Activities -
Our indebtedness could limit our flexibility and adversely affect our financial
condition" and "ITEM 1A. RISK FACTORS - Risks Related to Our Business - The
effects of the ongoing coronavirus (COVID-19) pandemic and any possible
recurrence of other similar types of pandemics, or any other widespread public
health emergencies, could have a material adverse effect on our business,
results of operations, financial condition and/or cash flows."

Financial Disclosures About Guarantors and Issuers of Guaranteed Securities

The 5.250% Senior Notes, 4.500% Senior Notes, 4.000% Senior Notes and 4.375% Senior Notes (collectively, the "Senior Notes") were issued by Scotts Miracle-Gro on December 15, 2016, October 22, 2019, March 17, 2021 and August 13, 2021, respectively. The Senior Notes are guaranteed by certain consolidated domestic subsidiaries of Scotts Miracle-Gro (collectively, the "Guarantors") and, therefore, we report summarized financial information in accordance with SEC Regulation S-X, Rule 13-01, "Guarantors and Issuers of Guaranteed Securities Registered or Being Registered."



The guarantees are "full and unconditional," as those terms are used in
Regulation S-X, Rule 3-10(b)(3), except that a Guarantor's guarantee will be
released in certain circumstances set forth in the indentures governing the
Senior Notes, such as: (i) upon any sale or other disposition of all or
substantially all of the assets of the Guarantor (including by way of merger or
consolidation) to any person other than Scotts Miracle-Gro or any "restricted
subsidiary" under the applicable indenture; (ii) if the Guarantor merges with
and into Scotts Miracle-Gro, with Scotts Miracle-Gro surviving such merger;
(iii) if the Guarantor is designated an "unrestricted subsidiary" in accordance
with the applicable indenture or otherwise ceases to be a "restricted
subsidiary" (including by way of liquidation or dissolution) in a transaction
permitted by such indenture; (iv) upon legal or covenant defeasance; (v) at the
election of Scotts Miracle-Gro following the Guarantor's release as a guarantor
under the Sixth A&R Credit Agreement, except a release by or as a result of the
repayment of the Sixth A&R Credit Agreement; or (vi) if the Guarantor ceases to
be a "restricted subsidiary" and the Guarantor is not otherwise required to
provide a guarantee of the Senior Notes pursuant to the applicable indenture.

Our foreign subsidiaries and certain of our domestic subsidiaries are not
guarantors (collectively, the "Non-Guarantors") on the Senior Notes. Payments on
the Senior Notes are only required to be made by Scotts Miracle-Gro and the
Guarantors. As a result, no payments are required to be made from the assets of
the Non-Guarantors, unless those assets are transferred by dividend or otherwise
to Scotts Miracle-Gro or a Guarantor. In the event of a bankruptcy, insolvency,
liquidation or reorganization of any of the Non-Guarantors, holders of their
indebtedness, including their trade creditors and other obligations,
                                       43
--------------------------------------------------------------------------------
  Contents             THE SCOTTS MIRACLE-GRO COMPANY
                (Dollars in millions, except per share data)


will be entitled to payment of their claims from the assets of the
Non-Guarantors before any assets are made available for distribution to Scotts
Miracle-Gro or the Guarantors. As a result, the Senior Notes are effectively
subordinated to all the liabilities of the Non-Guarantors.

The guarantees may be subject to review under federal bankruptcy laws or
relevant state fraudulent conveyance or fraudulent transfer laws. In certain
circumstances, the court could void the guarantee, subordinate the amounts owing
under the guarantee, or take other actions detrimental to the holders of the
Senior Notes.

As a general matter, value is given for a transfer or an obligation if, in
exchange for the transfer or obligation, property is transferred or a valid
antecedent debt is satisfied. A court would likely find that a Guarantor did not
receive reasonably equivalent value or fair consideration for its guarantee to
the extent such Guarantor did not obtain a reasonably equivalent benefit from
the issuance of the Senior Notes.

The measure of insolvency varies depending upon the law of the jurisdiction that
is being applied. Regardless of the measure being applied, a court could
determine that a Guarantor was insolvent on the date the guarantee was issued,
so that payments to the holders of the Senior Notes would constitute a
preference, fraudulent transfer or conveyances on other grounds. If a guarantee
is voided as a fraudulent conveyance or is found to be unenforceable for any
other reason, the holders of the Senior Notes will not have a claim against the
Guarantor.

Each guarantee contains a provision intended to limit the Guarantor's liability
to the maximum amount that it could incur without causing the incurrence of
obligations under its guarantee to be a fraudulent conveyance. However, there
can be no assurance as to what standard a court will apply in making a
determination of the maximum liability of each Guarantor. Moreover, this
provision may not be effective to protect the guarantees from being voided under
fraudulent conveyance laws. There is a possibility that the entire guarantee may
be set aside, in which case the entire liability may be extinguished.

The following tables present summarized financial information on a combined
basis for Scotts Miracle-Gro and the Guarantors. Transactions between Scotts
Miracle-Gro and the Guarantors have been eliminated and the summarized financial
information does not reflect investments of the Scotts Miracle-Gro and the
Guarantors in the Non-Guarantor subsidiaries.
                           July 2,       September 30,
                            2022              2021

Current assets           $ 2,305.2      $      1,834.8
Noncurrent assets (a)      2,251.4             2,484.5
Current liabilities          959.5             1,038.1
Noncurrent liabilities     3,393.0             2,611.8


(a)Includes amounts due from Non-Guarantor subsidiaries of $54.3 and $39.8,
respectively.

                                                              Nine Months
                                                                 Ended               Year Ended
                                                                July 2,             September 30,
                                                                 2022                   2021

Net sales                                                   $    3,139.2          $      4,507.6
Gross profit                                                       898.6                 1,380.6
Income (loss) from continuing operations (a)                      (124.5)                  510.9
Net income (loss)                                                 (124.5)                  510.8
Net income (loss) attributable to controlling interest            (124.5)                  509.9


(a)Includes intercompany income from Non-Guarantor subsidiaries of $17.8 and $26.3, respectively.

Judicial and Administrative Proceedings



We are party to various pending judicial and administrative proceedings arising
in the ordinary course of business, including, among others, proceedings based
on accidents or product liability claims and alleged violations of environmental
laws. We have reviewed these pending judicial and administrative proceedings,
including the probable outcomes, reasonably anticipated costs and expenses, and
the availability and limits of our insurance coverage, and have established what
we believe to be appropriate accruals. We believe that our assessment of
contingencies is reasonable and that the related accruals, in the aggregate, are
adequate; however, there can be no assurance that future quarterly or annual
operating results will not be materially affected by these proceedings, whether
as a result of adverse outcomes or as a result of significant defense costs.
                                       44
--------------------------------------------------------------------------------
  Contents             THE SCOTTS MIRACLE-GRO COMPANY
                (Dollars in millions, except per share data)


REGULATORY MATTERS



We are subject to local, state, federal and foreign environmental protection
laws and regulations with respect to our business operations and believe we are
operating in substantial compliance with, or taking actions aimed at ensuring
compliance with, such laws and regulations. We are involved in several legal
actions with various governmental agencies related to environmental matters.
While it is difficult to quantify the potential financial impact of actions
involving these environmental matters, particularly remediation costs at waste
disposal sites and future capital expenditures for environmental control
equipment, in the opinion of management, the ultimate liability arising from
such environmental matters, taking into account established accruals, is not
expected to have a material effect on our financial condition, results of
operations or cash flows. However, there can be no assurance that the resolution
of these matters will not materially affect our future quarterly or annual
results of operations, financial condition or cash flows. Additional information
on environmental matters affecting us is provided in the 2021 Annual Report,
under "ITEM 1. BUSINESS - Regulatory Considerations" and "ITEM 3. LEGAL
PROCEEDINGS."

CRITICAL ACCOUNTING POLICIES AND ESTIMATES



The preparation of financial statements requires management to use judgment and
make estimates that affect the reported amounts of assets, liabilities, revenues
and expenses and related disclosures of contingent assets and liabilities. We
evaluate our estimates on an ongoing basis. By their nature, these judgments are
subject to uncertainty. We base our estimates on historical experience and on
various other sources that we believe to be reasonable under the circumstances.
Certain accounting policies are particularly significant, including those
related to revenue recognition, income taxes and goodwill and intangible assets.
Our critical accounting policies are reviewed periodically with the Audit
Committee of the Board of Directors of Scotts Miracle-Gro. Our critical
accounting policies and estimates have not changed materially from those
disclosed in the 2021 Annual Report, with the exception of the item discussed
below.

During the third quarter of fiscal 2022, our Hawthorne reporting unit continued
to experience adverse financial results driven by an oversupply of cannabis,
which has slowed down indoor and outdoor cultivation, and higher transportation
and warehousing costs. As a result, we made further revisions to our internal
forecasts relating to our Hawthorne reporting unit. We concluded that the
changes in circumstances in this reporting unit and the decline in the Company's
market capitalization triggered the need for an interim impairment review of its
goodwill. We elected to bypass the qualitative assessment and perform
quantitative interim goodwill impairment testing for our Hawthorne reporting
unit. We updated our assumptions from prior periods to include the longer
duration and increased significance of lower sales volumes and cost increases.
This quantitative test resulted in a non-cash, pre-tax goodwill impairment
charge of $522.4 related to our Hawthorne reporting unit, which was recorded in
the "Impairment, restructuring and other" line in the Condensed Consolidated
Statements of Operations. The carrying value of goodwill of our Hawthorne
reporting unit, after recognizing the impairment, is zero. The estimated fair
value of our Hawthorne reporting unit was based upon an equal weighting of the
income-based and market-based approaches, utilizing estimated cash flows and a
terminal value, discounted at a rate of return that reflects the relative risk
of the cash flows, as well as valuation multiples derived from comparable
publicly traded companies that are applied to operating performance of the
reporting unit. The fair value estimate utilizes significant unobservable inputs
and thus represents a Level 3 fair value measurement. While we consider our
assumptions to be reasonable and appropriate, they are complex and subjective.
Refer to "NOTE 4. GOODWILL AND INTANGIBLE ASSETS" for more information.

© Edgar Online, source Glimpses